PER-001, delivered through a slow-release, dissolvable implant in the vitreous cavity of the eye, is designed to block ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

The development of drug delivery platforms that offer sustained release of therapeutic agents in the retina represents a ...

Re-Vana Therapeutics is collaborating with Boehringer Ingelheim to develop extended-release therapies for ophthalmic diseases ...

New study went head-to-head with HA vs. HA spiked with a little PRP magic. Spoiler alert: both help with pain.

Regenerative medicine is an evolving field that focuses on harnessing the body’s intrinsic ability to repair and restore damaged tissues. Autologous ...

Anti-CGRP monoclonal antibody therapy in patients with migraine can reduce headache burden and stabilize retinal and optic nerve changes.